Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer — Stella

Home/Endometrial Neoplasms/Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

View on ClinicalTrials.gov

Recruiting

Back to Endometrial Neoplasms trials

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Peking University People's Hosoital, Beijing, Beijing Municipality

Key details

Sponsor

Peking University People's Hospital

Collaborators

Peking University Third Hospital, Peking Union Medical College Hospital

Enrollment target

~57 participants

Started

August 2016

Primary completion

December 2023

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 45 Years

Sex

Female only

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.